Lisa Kierstead

3.0k total citations · 1 hit paper
20 papers, 1.9k citations indexed

About

Lisa Kierstead is a scholar working on Immunology, Virology and Oncology. According to data from OpenAlex, Lisa Kierstead has authored 20 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 7 papers in Virology and 7 papers in Oncology. Recurrent topics in Lisa Kierstead's work include Immunotherapy and Immune Responses (10 papers), HIV Research and Treatment (7 papers) and T-cell and B-cell Immunology (6 papers). Lisa Kierstead is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), HIV Research and Treatment (7 papers) and T-cell and B-cell Immunology (6 papers). Lisa Kierstead collaborates with scholars based in United States, Singapore and Italy. Lisa Kierstead's co-authors include Walter J. Storkus, Danilo R. Casimiro, John W. Shiver, John M. Kirkwood, Sheri Dubey, Elena Ranieri, Devan V. Mehrotra, Michael Robertson, Loreto Gesualdo and Steven G. Self and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Medicine.

In The Last Decade

Lisa Kierstead

20 papers receiving 1.9k citations

Hit Papers

HIV-1 vaccine-induced immunity in the test-of-concept Ste... 2008 2026 2014 2020 2008 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
    2008 517 citations M. Juliana McElrath, Stephen C. De Rosa et al. The Lancet profile →

Peers

Lisa Kierstead
Natalie A. Hutnick United States
Daniel G. Kavanagh United States
Pierre Langlade‐Demoyen France
Margherita Rosati United States
Marnix L. Bosch United States
Hanne Gahéry‐Ségard France
Stefano M. Santini Italy
J M McCune United States
Antonio Valentin United States
Wynetta Giles‐Davis United States
Natalie A. Hutnick United States
Lisa Kierstead
Citations per year, relative to Lisa Kierstead Lisa Kierstead (= 1×) peers Natalie A. Hutnick

Countries citing papers authored by Lisa Kierstead

Since Specialization
Citations

This map shows the geographic impact of Lisa Kierstead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Kierstead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Kierstead more than expected).

Fields of papers citing papers by Lisa Kierstead

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Kierstead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Kierstead. The network helps show where Lisa Kierstead may publish in the future.

Co-authorship network of co-authors of Lisa Kierstead

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Kierstead. A scholar is included among the top collaborators of Lisa Kierstead based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Kierstead. Lisa Kierstead is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonhomme, C, Lisa Strelow, Atul A. Chaudhari, et al.. (2022). Robust validation and performance comparison of immunogenicity assays assessing IgG and neutralizing antibodies to SARS-CoV-2. PLoS ONE. 17(2). e0262922–e0262922. 8 indexed citations
2.
Hutnick, Natalie A., Diane G. Carnathan, Sheri Dubey, et al.. (2010). Vaccination with Ad5 Vectors Expands Ad5-Specific CD8+ T Cells without Altering Memory Phenotype or Functionality. PLoS ONE. 5(12). e14385–e14385. 10 indexed citations
3.
Nicholson, Ouzama, James G. Kublin, Xiao Sun, et al.. (2010). Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults. AIDS Research and Human Retroviruses. 27(5). 557–567. 16 indexed citations
4.
Hutnick, Natalie A., Diane G. Carnathan, Sheri Dubey, et al.. (2009). Baseline Ad5 serostatus does not predict Ad5 HIV vaccine–induced expansion of adenovirus-specific CD4+ T cells. Nature Medicine. 15(8). 876–878. 71 indexed citations
5.
Asmuth, David M., Elizabeth Brown, Mark J. DiNubile, et al.. (2009). Comparative Cell‐Mediated Immunogenicity of DNA/DNA, DNA/Adenovirus Type 5 (Ad5), or Ad5/Ad5 HIV‐1 Clade BgagVaccine Prime‐Boost Regimens. The Journal of Infectious Diseases. 201(1). 132–141. 38 indexed citations
6.
7.
Harro, Clayton, Michael Robertson, Michelle Lally, et al.. (2008). Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade B gag Vaccines in Healthy Adults. AIDS Research and Human Retroviruses. 25(1). 103–114. 46 indexed citations
8.
McElrath, M. Juliana, Stephen C. De Rosa, Zoe Moodie, et al.. (2008). HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis. The Lancet. 372(9653). 1894–1905. 517 indexed citations breakdown →
9.
Kierstead, Lisa, Sheri Dubey, Timothy W. Tobery, et al.. (2007). Enhanced Rates and Magnitude of Immune Responses Detected against an HIV Vaccine: Effect of Using an Optimized Process for Isolating PBMC. AIDS Research and Human Retroviruses. 23(1). 86–92. 60 indexed citations
10.
Dubey, Sheri, J. Clair, Tong‐Ming Fu, et al.. (2007). Detection of HIV Vaccine-Induced Cell-Mediated Immunity in HIV-Seronegative Clinical Trial Participants Using an Optimized and Validated Enzyme-Linked Immunospot Assay. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(1). 20–27. 74 indexed citations
11.
Esser, Mark T., Rocio D. Marchese, Lisa Kierstead, et al.. (2003). Memory T cells and vaccines. Vaccine. 21(5-6). 419–430. 147 indexed citations
12.
Tatsumi, Tomohide, Lisa Kierstead, Elena Ranieri, et al.. (2003). MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma.. PubMed. 9(3). 947–54. 49 indexed citations
13.
Tatsumi, Tomohide, Lisa Kierstead, Elena Ranieri, et al.. (2002). Disease-associated Bias in T Helper Type 1 (Th1)/Th2 CD4+ T Cell Responses Against MAGE-6 in HLA-DRB10401+ Patients With Renal Cell Carcinoma or Melanoma. The Journal of Experimental Medicine. 196(5). 619–628. 242 indexed citations
14.
Kierstead, Lisa, Elena Ranieri, Walter C. Olson, et al.. (2001). gp100/pmel17 and tyrosinase encode multiple epitopes recognized by Th1-type CD4+T cells. British Journal of Cancer. 85(11). 1738–1745. 40 indexed citations
15.
Dong, Xin, Bing An, Lisa Kierstead, et al.. (2000). Modification of the Amino Terminus of a Class II Epitope Confers Resistance to Degradation by CD13 on Dendritic Cells and Enhances Presentation to T Cells. The Journal of Immunology. 164(1). 129–135. 32 indexed citations
16.
Zarour, Hassane M., John M. Kirkwood, Lisa Kierstead, et al.. (2000). Melan-A/MART-151–73represents an immunogenic HLA-DR4-restricted epitope recognized by melanoma-reactive CD4+T cells. Proceedings of the National Academy of Sciences. 97(1). 400–405. 136 indexed citations
17.
Ranieri, Elena, Lisa Kierstead, Hassane M. Zarour, et al.. (2000). Dendritic Cell/Peptide Cancer Vaccines: Clinical Responsiveness and Epitope Spreading. Immunological Investigations. 29(2). 121–125. 59 indexed citations
18.
Herr, Wolfgang, Elena Ranieri, Andrea Gambotto, et al.. (1999). Identification of naturally processed and HLA-presented Epstein–Barr virus peptides recognized by CD4+or CD8+T lymphocytes from human blood. Proceedings of the National Academy of Sciences. 96(21). 12033–12038. 57 indexed citations
19.
Ranieri, Elena, W. Herr, Andrea Gambotto, et al.. (1999). Dendritic Cells Transduced with an Adenovirus Vector Encoding Epstein-Barr Virus Latent Membrane Protein 2B: a New Modality for Vaccination. Journal of Virology. 73(12). 10416–10425. 63 indexed citations
20.
Resnick, Neil M., Mark S. F. Clarke, Jill M. Siegfried, et al.. (1998). Expression of the cell adhesion molecule CD44 in human lung tumors and cell lines*. Molecular Diagnosis. 3(2). 93–103. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Natalie A. Hutnick Breakdown of academic impact, for papers by Daniel G. Kavanagh Breakdown of academic impact, for papers by Pierre Langlade‐Demoyen Breakdown of academic impact, for papers by Margherita Rosati Breakdown of academic impact, for papers by Marnix L. Bosch Breakdown of academic impact, for papers by Hanne Gahéry‐Ségard Breakdown of academic impact, for papers by Stefano M. Santini Breakdown of academic impact, for papers by J M McCune Breakdown of academic impact, for papers by Antonio Valentin Breakdown of academic impact, for papers by Wynetta Giles‐Davis
Rankless by CCL
2026